Evidence map›Paper›PMID 41426171›Full record

ArticleSouth Asian journal of cancer2025

Patterns of Failure in Head and Neck Carcinoma of Unknown Primary: Insights from a Tobacco-Associated Cancer Cohort.

Sarbani Ghosh Laskar, Jifmi Jose Manjali, Ashwini Budrukkar, Monali Swain, Debanjali Dutta, Amrendra Kumar, Sahil Sood, Shwetabh Sinha, Anuj Kumar, Samarpita Mohanty and 15 more

Abstract read
In one paragraph

Article in South Asian journal of cancer, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

25 authors.

Sarbani Ghosh LaskarDepartment of Radiation Oncology, Tata Memorial Centre (TMH/ACTREC), Mumbai, Maharashtra, India.ORCID 0000-0003-0744-4838
Jifmi Jose ManjaliDepartment of Radiation Oncology, Tata Memorial Centre (TMH/ACTREC), Mumbai, Maharashtra, India.
Ashwini BudrukkarDepartment of Radiation Oncology, Tata Memorial Centre (TMH/ACTREC), Mumbai, Maharashtra, India.
Monali SwainDepartment of Radiation Oncology, Tata Memorial Centre (TMH/ACTREC), Mumbai, Maharashtra, India.
Debanjali DuttaDepartment of Radiation Oncology, Tata Memorial Centre (TMH/ACTREC), Mumbai, Maharashtra, India.
Amrendra KumarDepartment of Radiation Oncology, Tata Memorial Centre (TMH/ACTREC), Mumbai, Maharashtra, India.
Sahil SoodDepartment of Radiation Oncology, Tata Memorial Centre (TMH/ACTREC), Mumbai, Maharashtra, India.ORCID 0000-0002-9646-0153
Shwetabh SinhaDepartment of Radiation Oncology, Tata Memorial Centre (TMH/ACTREC), Mumbai, Maharashtra, India.
Anuj KumarDepartment of Radiation Oncology, Tata Memorial Centre (TMH/ACTREC), Mumbai, Maharashtra, India.
Samarpita MohantyDepartment of Radiation Oncology, Tata Memorial Centre (TMH/ACTREC), Mumbai, Maharashtra, India.
Tejpal GuptaDepartment of Radiation Oncology, Tata Memorial Centre (TMH/ACTREC), Mumbai, Maharashtra, India.
Vedang MurthyDepartment of Radiation Oncology, Tata Memorial Centre (TMH/ACTREC), Mumbai, Maharashtra, India.
Pankaj ChaturvediHomi Bhabha National Institute (HBNI), Mumbai, Maharashtra, India.
Devendra Arvind ChaukarHomi Bhabha National Institute (HBNI), Mumbai, Maharashtra, India.
Prathamesh PaiHomi Bhabha National Institute (HBNI), Mumbai, Maharashtra, India.ORCID 0000-0001-9989-5534
Gouri PantavaidyaHomi Bhabha National Institute (HBNI), Mumbai, Maharashtra, India.
Anuja DeshmukhHomi Bhabha National Institute (HBNI), Mumbai, Maharashtra, India.
Deepa NairHomi Bhabha National Institute (HBNI), Mumbai, Maharashtra, India.
Shivakumar ThiagarajanHomi Bhabha National Institute (HBNI), Mumbai, Maharashtra, India.
Richa VaishHomi Bhabha National Institute (HBNI), Mumbai, Maharashtra, India.
Kumar PrabhashHomi Bhabha National Institute (HBNI), Mumbai, Maharashtra, India.
Amit JoshiHomi Bhabha National Institute (HBNI), Mumbai, Maharashtra, India.
Vanita NoronhaHomi Bhabha National Institute (HBNI), Mumbai, Maharashtra, India.ORCID 0000-0002-0191-2744
Nandini MenonHomi Bhabha National Institute (HBNI), Mumbai, Maharashtra, India.ORCID 0000-0002-4214-5799
Jai Prakash AgarwalDepartment of Radiation Oncology, Tata Memorial Centre (TMH/ACTREC), Mumbai, Maharashtra, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: We report the patterns of failure and survival with carcinoma of unknown primary of the head and neck (CUP-HN). Materials and Methods: This is a retrospective audit of CUP-HN patients treated with curative radiotherapy (RT) between January 2006 and December 2020. All patients received RT to the neck-definitive RT (DRT) or surgery (Sx) + adjuvant RT (ART), ± chemotherapy. Results: Of the 108 eligible patients, 81 (75%) used tobacco. Positron emission tomography with computed tomography was performed in 102 patients (94.4%). Seventy-five patients (69.4%) were treated with DRT ± chemotherapy, while 33 (30.6%) underwent Sx + ART ± chemotherapy. Median lymph node size was significantly different between DRT and ART groups (5 vs. 3.5cm, Conclusion: All SMPs developed in the oral cavity in this tobacco-driven population. Inclusion of oral cavity for CMI may be considered in tobacco-driven populations; however, this has to be weighed against the toxicity involved.

Indexed as

cervical lymph nodesCUP-HNhead and neck cancerradiotherapyunknown primary

Identifiers

PMID41426171
PMCPMC12714480

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.